Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vagus nerve stimulation therapy.

James W Wheless1, James Baumgartner

  • 1Texas Comprehensive Epilepsy Program, University of Texas-Houston, Epilepsy Monitoring Unit, Memorial Hermann Hospital, Houston, Texas 77030, USA. james.w.wheless@uth.tmc.edu

Drugs of Today (Barcelona, Spain : 1998)
|September 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased interval between seizure clusters across time in pediatric patients treated with the immediate-use seizure medication diazepam nasal spray.

Epilepsia·2026
Same author

Postapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy: Three-Year Efficacy and Interim Safety Results.

Neurology·2026
Same author

Utilization of Stiripentol in Children With Developmental and Epileptic Encephalopathies: Considerations for Clinical Practice.

Pediatric neurology·2026
Same author

State-of-the-Art Management of Children with Intractable Epilepsy and Brain Tumors.

Pediatric neurosurgery·2026
Same author

Safety and effectiveness of diazepam nasal spray in patients with Rett syndrome and seizure clusters: <i>post hoc</i> analyses from a long-term safety study and survey of severity and burden.

Frontiers in neurology·2026
Same author

Zorevunersen in Children and Adolescents with Dravet Syndrome.

The New England journal of medicine·2026
Same journal

Monoclonal antibodies for treatment of osteoporosis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Mitapivat for sickle cell disease and thalassemia.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Cenegermin for the treatment of dry eye disease.

Drugs of today (Barcelona, Spain : 1998)·2023
See all related articles

Vagus nerve stimulation (VNS) therapy offers an effective alternative for epilepsy treatment, reducing seizure frequency and improving quality of life without drug side effects. This overview covers VNS history, patient selection, and emerging indications.

Area of Science:

  • Neurology
  • Neurosurgery
  • Biomedical Engineering

Background:

  • Epilepsy treatment traditionally relies on antiepileptic drugs and surgery, which have limitations.
  • Antiepileptic drugs may not control seizures and can cause side effects.
  • Epilepsy surgery is only suitable for a small subset of patients.

Purpose of the Study:

  • To provide an overview of Vagus Nerve Stimulation (VNS) therapy.
  • To discuss the VNS therapy system and its history.
  • To outline patient selection guidelines and explore new indications for VNS.

Main Methods:

  • Review of existing literature on Vagus Nerve Stimulation therapy.
  • Analysis of the VNS therapy system components and mechanism.
  • Examination of patient selection criteria and current research on new applications.

Related Experiment Videos

Main Results:

  • VNS therapy is an FDA-approved treatment option since 1997.
  • VNS effectively reduces seizure frequency and severity.
  • VNS improves patient quality of life without the side effects of antiepileptic drugs.

Conclusions:

  • Vagus Nerve Stimulation therapy presents a viable alternative for epilepsy management.
  • Further research is exploring expanded indications for VNS therapy.
  • VNS offers a promising approach to enhance epilepsy care and patient outcomes.